Related Experiment Video
Updated: Mar 7, 2026
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
DNA vaccines for prostate cancer
Christopher D Zahm1, Viswa Teja Colluru1, Douglas G McNeel1
1Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705, United States.
Abstract:
DNA vaccines offer many advantages over other anti-tumor vaccine approaches due to their simplicity, ease of manufacturing, and safety. Results from several clinical trials in patients with cancer have demonstrated that DNA vaccines are safe and can elicit immune responses. However, to date few DNA vaccines have progressed beyond phase I clinical trial evaluation. Studies into the mechanism of action of DNA vaccines in terms of antigen-presenting cell types able to directly present or cross-present DNA-encoded antigens, and the activation of innate immune responses due to DNA itself, have suggested opportunities to increase the immunogenicity of these vaccines. In addition, studies into the mechanisms of tumor resistance to anti-tumor vaccination have suggested combination approaches that can increase the anti-tumor effect of DNA vaccines. This review focuses on these mechanisms of action and mechanisms of resistance using DNA vaccines, and how this information is being used to improve the anti-tumor effect of DNA vaccines. These approaches are then specifically discussed in the context of human prostate cancer, a disease for which DNA vaccines have been and continue to be explored as treatments.
Insights
DNA vaccines are safe and can trigger immune responses against cancer. Research is exploring how to enhance their effectiveness by understanding immune cell interactions and overcoming tumor resistance, particularly for prostate cancer treatments.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- DNA vaccines offer advantages in simplicity, manufacturing, and safety for anti-tumor vaccination.
- Clinical trials show DNA vaccines are safe and elicit immune responses, but few advance past Phase I.
- Understanding DNA vaccine mechanisms and tumor resistance offers avenues for improved immunogenicity and efficacy.
Purpose of the Study:
- To review the mechanisms of action for DNA vaccines in anti-tumor therapy.
- To explore mechanisms of tumor resistance to vaccination.
- To discuss strategies for enhancing DNA vaccine anti-tumor effects, with a focus on prostate cancer.
Main Methods:
- Review of existing literature on DNA vaccine mechanisms.
- Analysis of studies on antigen presentation and innate immune activation by DNA vaccines.
- Examination of research into tumor resistance mechanisms and combination therapies.
Main Results:
- Studies suggest enhancing DNA vaccine immunogenicity through optimized antigen presentation and innate immune stimulation.
- Combination approaches targeting tumor resistance mechanisms can improve anti-tumor effects.
- DNA vaccines are actively being explored for human prostate cancer treatment.
Conclusions:
- Understanding DNA vaccine action and resistance pathways is crucial for improving anti-tumor efficacy.
- Strategies to boost immunogenicity and overcome resistance hold promise for advancing DNA vaccine therapy.
- Further development is needed to translate promising preclinical findings into successful clinical applications, especially for prostate cancer.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:51Vaccinations